View in EDS HTML Full Text PDF Full Text

Phase II study of zevorcabtagene autoleucel, a fully human BCMA-targeting CAR T cell therapy, in patients with relapsed/refractory multiple myeloma.

Saved in:
Bibliographic Details
Title: Phase II study of zevorcabtagene autoleucel, a fully human BCMA-targeting CAR T cell therapy, in patients with relapsed/refractory multiple myeloma.
Authors: Chen, Wenming1 (AUTHOR) 13910107759@163.com, Fu, Chengcheng2 (AUTHOR) fuchengchengsz@163.com, Fang, Baijun3 (AUTHOR), Liang, Aibin4 (AUTHOR), Xia, Zhongjun5 (AUTHOR), He, Yanjuan6 (AUTHOR), Lu, Jin7 (AUTHOR), Liu, Hui8 (AUTHOR), Hou, Ming9 (AUTHOR), Cai, Zhen10 (AUTHOR), Yang, Wei11 (AUTHOR), Hao, Siguo12 (AUTHOR), Jiang, Songfu13 (AUTHOR), Jing, Hongmei14 (AUTHOR), Liu, Jing15 (AUTHOR), Du, Xin16 (AUTHOR), Fu, Rong17 (AUTHOR), Mei, Heng18 (AUTHOR), Zhu, Zunmin19 (AUTHOR), Yang, Yanli20 (AUTHOR)
Source: Experimental Hematology & Oncology. 9/30/2025, Vol. 14 Issue 1, p1-14. 14p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: asn
DbLabel: Academic Search Ultimate
An: 188354173
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Phase II study of zevorcabtagene autoleucel, a fully human BCMA-targeting CAR T cell therapy, in patients with relapsed/refractory multiple myeloma.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Chen%2C+Wenming%22">Chen, Wenming</searchLink><relatesTo>1</relatesTo> (AUTHOR)<i> 13910107759@163.com</i><br /><searchLink fieldCode="AR" term="%22Fu%2C+Chengcheng%22">Fu, Chengcheng</searchLink><relatesTo>2</relatesTo> (AUTHOR)<i> fuchengchengsz@163.com</i><br /><searchLink fieldCode="AR" term="%22Fang%2C+Baijun%22">Fang, Baijun</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Liang%2C+Aibin%22">Liang, Aibin</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Xia%2C+Zhongjun%22">Xia, Zhongjun</searchLink><relatesTo>5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22He%2C+Yanjuan%22">He, Yanjuan</searchLink><relatesTo>6</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Lu%2C+Jin%22">Lu, Jin</searchLink><relatesTo>7</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Liu%2C+Hui%22">Liu, Hui</searchLink><relatesTo>8</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Hou%2C+Ming%22">Hou, Ming</searchLink><relatesTo>9</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Cai%2C+Zhen%22">Cai, Zhen</searchLink><relatesTo>10</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Yang%2C+Wei%22">Yang, Wei</searchLink><relatesTo>11</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Hao%2C+Siguo%22">Hao, Siguo</searchLink><relatesTo>12</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Jiang%2C+Songfu%22">Jiang, Songfu</searchLink><relatesTo>13</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Jing%2C+Hongmei%22">Jing, Hongmei</searchLink><relatesTo>14</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Liu%2C+Jing%22">Liu, Jing</searchLink><relatesTo>15</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Du%2C+Xin%22">Du, Xin</searchLink><relatesTo>16</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Fu%2C+Rong%22">Fu, Rong</searchLink><relatesTo>17</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Mei%2C+Heng%22">Mei, Heng</searchLink><relatesTo>18</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Zhu%2C+Zunmin%22">Zhu, Zunmin</searchLink><relatesTo>19</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Yang%2C+Yanli%22">Yang, Yanli</searchLink><relatesTo>20</relatesTo> (AUTHOR)
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22Experimental+Hematology+%26+Oncology%22">Experimental Hematology & Oncology</searchLink>. 9/30/2025, Vol. 14 Issue 1, p1-14. 14p.
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=188354173
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1186/s40164-025-00710-y
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 14
        StartPage: 1
    Titles:
      – TitleFull: Phase II study of zevorcabtagene autoleucel, a fully human BCMA-targeting CAR T cell therapy, in patients with relapsed/refractory multiple myeloma.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Chen, Wenming
      – PersonEntity:
          Name:
            NameFull: Fu, Chengcheng
      – PersonEntity:
          Name:
            NameFull: Fang, Baijun
      – PersonEntity:
          Name:
            NameFull: Liang, Aibin
      – PersonEntity:
          Name:
            NameFull: Xia, Zhongjun
      – PersonEntity:
          Name:
            NameFull: He, Yanjuan
      – PersonEntity:
          Name:
            NameFull: Lu, Jin
      – PersonEntity:
          Name:
            NameFull: Liu, Hui
      – PersonEntity:
          Name:
            NameFull: Hou, Ming
      – PersonEntity:
          Name:
            NameFull: Cai, Zhen
      – PersonEntity:
          Name:
            NameFull: Yang, Wei
      – PersonEntity:
          Name:
            NameFull: Hao, Siguo
      – PersonEntity:
          Name:
            NameFull: Jiang, Songfu
      – PersonEntity:
          Name:
            NameFull: Jing, Hongmei
      – PersonEntity:
          Name:
            NameFull: Liu, Jing
      – PersonEntity:
          Name:
            NameFull: Du, Xin
      – PersonEntity:
          Name:
            NameFull: Fu, Rong
      – PersonEntity:
          Name:
            NameFull: Mei, Heng
      – PersonEntity:
          Name:
            NameFull: Zhu, Zunmin
      – PersonEntity:
          Name:
            NameFull: Yang, Yanli
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 30
              M: 09
              Text: 9/30/2025
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-print
              Value: 21623619
          Numbering:
            – Type: volume
              Value: 14
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Experimental Hematology & Oncology
              Type: main
ResultId 1